MediciNova
MNOV
#9504
Rank
HK$0.59 B
Marketcap
HK$12.14
Share price
0.65%
Change (1 day)
-30.95%
Change (1 year)

Revenue for MediciNova (MNOV)

Revenue in 2025 (TTM): HK$1.05 Million

According to MediciNova's latest financial reports the company's current revenue (TTM ) is HK$1.04 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of HK$7.81 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MediciNova from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$1.05 M
2024 N/A-100%
2023 HK$7.81 M
2022 N/A-100%
2021 HK$31.48 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 HK$46.55 M648.3%
2012 HK$6.22 M
2011 N/A
2010 N/A
2009 N/A
2006 HK$2.05 M-67.08%
2005 HK$6.23 M63.62%
2004 HK$3.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
HK$462.55 B 44,145,696.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$369.96 B 35,308,543.45%๐Ÿ‡ซ๐Ÿ‡ท France
Alkermes
ALKS
HK$11.84 B 1,130,174.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$130.59 B 12,463,588.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$438.83 B 41,881,340.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland